ARTG 462219

Vercise Neural Navigator 5 - Implantable electrical stimulation device management software

ARTG ID: 462219 · Boston Scientific Pty Ltd · Boston Scientific Neuromodulation Corporation · Class III · Started September 12, 2024

Good Name: Boston Scientific Pty Ltd - Vercise Neural Navigator 5 - Implantable electrical stimulation device management software

Device classification

Risk Class: Class III
Product Type: Single Device Product
ARTG Category: General

Registration information

ARTG ID: 462219
Start Date: September 12, 2024
Effective Date: September 12, 2024

Sponsor

Name: Boston Scientific Pty Ltd

Manufacturer

Name: Boston Scientific Neuromodulation Corporation
Country: United States of America
Address: 25155 Rye Canyon Loop, Valencia, CA, 91355

Intended purpose

Intended to set and adjust stimulation parameters for the compatible Boston Scientific Stimulator.

About this record

Access comprehensive regulatory information for Vercise Neural Navigator 5 - Implantable electrical stimulation device management software in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 462219 and sponsored by Boston Scientific Pty Ltd, manufactured by Boston Scientific Neuromodulation Corporation in United States of America. The device registration started on September 12, 2024.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.